Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis
- PMID: 14570710
- DOI: 10.1093/hmg/ddg352
Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis
Abstract
Huntington disease is caused by the expansion of a CAG repeat encoding an extended glutamine tract in a protein called huntingtin. Although the mutant protein is widely expressed, the earliest and most striking neuropathological changes are observed in the striatum. Here we show dramatic mutation length increases (gains of up to 1000 CAG repeats) in human striatal cells early in the disease course, most likely before the onset of pathological cell loss. Studies of knock-in HD mouse models indicate that the size of the initial CAG repeat mutation may influence both onset and tissue-specific patterns of age-dependent, expansion-biased mutation length variability. Given that CAG repeat length strongly correlates with clinical severity, we suggest that somatic increases of mutation length may play a major role in the progressive nature and cell-selective aspects of both adult-onset and juvenile-onset HD pathogenesis and we discuss the implications of this interpretation of the data presented.
Similar articles
-
Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain.Hum Mol Genet. 2007 May 15;16(10):1133-42. doi: 10.1093/hmg/ddm054. Epub 2007 Apr 4. Hum Mol Genet. 2007. PMID: 17409200
-
Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.Hum Mol Genet. 1999 Jan;8(1):115-22. doi: 10.1093/hmg/8.1.115. Hum Mol Genet. 1999. PMID: 9887339
-
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434303 Free PMC article.
-
The use of transgenic and knock-in mice to study Huntington's disease.Cytogenet Genome Res. 2003;100(1-4):276-86. doi: 10.1159/000072863. Cytogenet Genome Res. 2003. PMID: 14526189 Review.
-
Mouse models of Huntington's disease.Trends Pharmacol Sci. 2002 Jan;23(1):32-9. doi: 10.1016/s0165-6147(00)01884-8. Trends Pharmacol Sci. 2002. PMID: 11804649 Review.
Cited by
-
Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases.J Huntingtons Dis. 2021;10(1):203-220. doi: 10.3233/JHD-200421. J Huntingtons Dis. 2021. PMID: 32925081 Free PMC article. Review.
-
Trinucleotide repeat deletion via a unique hairpin bypass by DNA polymerase β and alternate flap cleavage by flap endonuclease 1.Nucleic Acids Res. 2013 Feb 1;41(3):1684-97. doi: 10.1093/nar/gks1306. Epub 2012 Dec 20. Nucleic Acids Res. 2013. PMID: 23258707 Free PMC article.
-
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease.Hum Mol Genet. 2010 Sep 1;19(17):3354-71. doi: 10.1093/hmg/ddq247. Epub 2010 Jun 17. Hum Mol Genet. 2010. PMID: 20558522 Free PMC article.
-
Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.Am J Hum Genet. 2019 Jun 6;104(6):1116-1126. doi: 10.1016/j.ajhg.2019.04.007. Epub 2019 May 16. Am J Hum Genet. 2019. PMID: 31104771 Free PMC article.
-
Unusual structures are present in DNA fragments containing super-long Huntingtin CAG repeats.PLoS One. 2011 Feb 11;6(2):e17119. doi: 10.1371/journal.pone.0017119. PLoS One. 2011. PMID: 21347256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases